Home > Offer to Sell > Intermediates > Pharmaceutical intermediates > 5-Methyl-2-pyrazinecarboxylic acid
5-Methyl-2-pyrazinecarboxylic acid
Inquiry
| Post Date: | Jul 11,2013 |
| Expiry Date: | Jul 11,2014 |
| Detailed Description: |
Cas No. :5521-55-1
Payment Method: TT;LC 5-Methyl-2-pyrazinecarboxylic acid Product details 5-Methyl-2-pyrazinecarboxylic acid Product Name: 5-Methyl-2-pyrazinecarboxylic acid Synonyms: 3-Carboxy-5-methylpyrazine; 5-methyl-pyrazinecarboxylicaci; 5MPZA; 5-METHYL-2-PYRAZINECARBOXYLIC ACID; 2-METHYL-5-PYRAZINE CARBOXYLIC ACID; 2-METHYL-5-PYRAZINOIC ACID; 2-METHYLPYRAZINE-5-CARBOXYLIC ACID; 5-Methylpyrazine-2-carobxylic acid; 5-Methylpyrazine-2-carboxylic acid CAS No: 5521-55-1 Content: 99% Packing: 25kg/barrel Molecular Formula: C6H6N2O2 Molecular Weight: 138.12 EINECS: 413-260-9 Quality Standards: Appearance: light yellow crystal |
| CAS Registry Number: | 5521-55-1 |
| Synonyms: | ;3-Carboxy-5-methylpyrazine;5-methyl-pyrazinecarboxylicaci;5MPZA;5-METHYL-2-PYRAZINECARBOXYLIC ACID;2-METHYL-5-PYRAZINE CARBOXYLIC ACID;2-METHYL-5-PYRAZINOIC ACID;2-METHYLPYRAZINE-5-CARBOXYLIC ACID;5-Methylpyrazine-2-carobxylic acid;5-methylpyrazine-2-carboxylate;5-Methyl-2-pyrazinecarboxylic acid; |
| Molecular Formula: | C6H6N2O2 |
| Molecular Weight: | 138.1166 |
| Molecular Structure: | 
|
| Hazard Symbols: |  Xi:Irritant; |
| Risk Codes: | R41:; |
| Safety Description: | S26:; S39:; |
| Company: | Wuhanyuancheng medical and pharmaceutical Co.,Ltd. [ China ] |
| Contact: | Ken Zheng |
| Tel: | +86-27-88083115 |
| Fax: | +86-27-88048077-972 |
| Email: | ken060214245@yuanchengtech.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
